5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole

C131H107F22N15O14S — CID 158252311

IUPAC5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
SMILESCOc1ccc(-c2ccc(-c3nc(-c4ccccc4OC(F)(F)F)no3)cc2C)c(OC)c1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3)c(C(F)(F)F)c2)n1.COc1ccccc1-c1noc(-c2ccc(-c3cscc3C)c(C(F)(F)F)c2)n1.COc1ccccc1-c1noc(-c2ccc(N3CCCCC3)c(C(F)(F)F)c2)n1.Cc1cc(-c2nc(-c3ccccc3OC(F)(F)F)no2)ccc1N1CCCCC1.Cc1ccccc1-c1ccc(-c2nc(-c3ccccc3OC(F)(F)F)no2)cc1C(F)(F)F
InChIInChI=1S/C24H19F3N2O4.C23H14F6N2O2.C21H19F4N3O2.2C21H20F3N3O2.C21H15F3N2O2S/c1-14-12-15(8-10-17(14)18-11-9-16(30-2)13-21(18)31-3)23-28-22(29-33-23)19-6-4-5-7-20(19)32-24(25,26)27;1-13-6-2-3-7-15(13)16-11-10-14(12-18(16)22(24,25)26)21-30-20(31-33-21)17-8-4-5-9-19(17)32-23(27,28)29;1-29-18-8-6-14(22)12-15(18)19-26-20(30-27-19)13-5-7-17(16(11-13)21(23,24)25)28-9-3-2-4-10-28;1-28-18-8-4-3-7-15(18)19-25-20(29-26-19)14-9-10-17(16(13-14)21(22,23)24)27-11-5-2-6-12-27;1-14-13-15(9-10-17(14)27-11-5-2-6-12-27)20-25-19(26-29-20)16-7-3-4-8-18(16)28-21(22,23)24;1-12-10-29-11-16(12)14-8-7-13(9-17(14)21(22,23)24)20-25-19(26-28-20)15-5-3-4-6-18(15)27-2/h4-13H,1-3H3;2-12H,1H3;5-8,11-12H,2-4,9-10H2,1H3;2*3-4,7-10,13H,2,5-6,11-12H2,1H3;3-11H,1-2H3
InChIKeyGGWDFABEMILFSW-UHFFFAOYSA-N
MW2565.41 g/mol
LogP36.64
Rot. Bonds26

About 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole

5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole (PubChem CID 158252311) has the molecular formula C131H107F22N15O14S and a molecular weight of 2565.41 g/mol. Its IUPAC name is 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole.

Molecular Properties

Compound Name5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
PubChem CID158252311
Molecular FormulaC131H107F22N15O14S
Molecular Weight2565.41 g/mol
Exact Mass2563.75
IUPAC Name5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
SMILESCOc1ccc(-c2ccc(-c3nc(-c4ccccc4OC(F)(F)F)no3)cc2C)c(OC)c1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3)c(C(F)(F)F)c2)n1.COc1ccccc1-c1noc(-c2ccc(-c3cscc3C)c(C(F)(F)F)c2)n1.COc1ccccc1-c1noc(-c2ccc(N3CCCCC3)c(C(F)(F)F)c2)n1.Cc1cc(-c2nc(-c3ccccc3OC(F)(F)F)no2)ccc1N1CCCCC1.Cc1ccccc1-c1ccc(-c2nc(-c3ccccc3OC(F)(F)F)no2)cc1C(F)(F)F
InChIInChI=1S/C24H19F3N2O4.C23H14F6N2O2.C21H19F4N3O2.2C21H20F3N3O2.C21H15F3N2O2S/c1-14-12-15(8-10-17(14)18-11-9-16(30-2)13-21(18)31-3)23-28-22(29-33-23)19-6-4-5-7-20(19)32-24(25,26)27;1-13-6-2-3-7-15(13)16-11-10-14(12-18(16)22(24,25)26)21-30-20(31-33-21)17-8-4-5-9-19(17)32-23(27,28)29;1-29-18-8-6-14(22)12-15(18)19-26-20(30-27-19)13-5-7-17(16(11-13)21(23,24)25)28-9-3-2-4-10-28;1-28-18-8-4-3-7-15(18)19-25-20(29-26-19)14-9-10-17(16(13-14)21(22,23)24)27-11-5-2-6-12-27;1-14-13-15(9-10-17(14)27-11-5-2-6-12-27)20-25-19(26-29-20)16-7-3-4-8-18(16)28-21(22,23)24;1-12-10-29-11-16(12)14-8-7-13(9-17(14)21(22,23)24)20-25-19(26-28-20)15-5-3-4-6-18(15)27-2/h4-13H,1-3H3;2-12H,1H3;5-8,11-12H,2-4,9-10H2,1H3;2*3-4,7-10,13H,2,5-6,11-12H2,1H3;3-11H,1-2H3
InChIKeyGGWDFABEMILFSW-UHFFFAOYSA-N
XLogP36.64
TPSA317.08 Ų
H-Bond Donors
H-Bond Acceptors30
Rotatable Bonds26
Heavy Atoms183
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002565.41
LogP ≤ 536.64
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1030

Analyze 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?
The IUPAC name of 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole (CID 158252311) is 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole.
What is the SMILES notation for 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?
The canonical SMILES for 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole is COc1ccc(-c2ccc(-c3nc(-c4ccccc4OC(F)(F)F)no3)cc2C)c(OC)c1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3)c(C(F)(F)F)c2)n1.COc1ccccc1-c1noc(-c2ccc(-c3cscc3C)c(C(F)(F)F)c2)n1.COc1ccccc1-c1noc(-c2ccc(N3CCCCC3)c(C(F)(F)F)c2)n1.Cc1cc(-c2nc(-c3ccccc3OC(F)(F)F)no2)ccc1N1CCCCC1.Cc1ccccc1-c1ccc(-c2nc(-c3ccccc3OC(F)(F)F)no2)cc1C(F)(F)F.
What is the InChIKey of 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?
The InChIKey is GGWDFABEMILFSW-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H19F3N2O4.C23H14F6N2O2.C21H19F4N3O2.2C21H20F3N3O2.C21H15F3N2O2S/c1-14-12-15(8-10-17(14)18-11-9-16(30-2)13-21(18)31-3)23-28-22(29-33-23)19-6-4-5-7-20(19)32-24(25,26)27;1-13-6-2-3-7-15(13)16-11-10-14(12-18(16)22(24,25)26)21-30-20(31-33-21)17-8-4-5-9-19(17)32-23(27,28)29;1-29-18-8-6-14(22)12-15(18)19-26-20(30-27-19)13-5-7-17(16(11-13)21(23,24)25)28-9-3-2-4-10-28;1-28-18-8-4-3-7-15(18)19-25-20(29-26-19)14-9-10-17(16(13-14)21(22,23)24)27-11-5-2-6-12-27;1-14-13-15(9-10-17(14)27-11-5-2-6-12-27)20-25-19(26-29-20)16-7-3-4-8-18(16)28-21(22,23)24;1-12-10-29-11-16(12)14-8-7-13(9-17(14)21(22,23)24)20-25-19(26-28-20)15-5-3-4-6-18(15)27-2/h4-13H,1-3H3;2-12H,1H3;5-8,11-12H,2-4,9-10H2,1H3;2*3-4,7-10,13H,2,5-6,11-12H2,1H3;3-11H,1-2H3.
What are the key properties of 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?
5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole has a molecular weight of 2565.41 g/mol, XLogP of 36.64, 26 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-(2,4-dimethoxyphenyl)-3-methylphenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(2-methoxyphenyl)-5-[4-piperidin-1-yl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;5-[4-(2-methylphenyl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-(3-methyl-4-piperidin-1-ylphenyl)-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole is sourced from PubChem (CID 158252311), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).